Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy
about
Dosage optimization in positron emission tomography: state-of-the-art methods and future prospectsState-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETClinical Utility of Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI) in Gastrointestinal CancersPrognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysisPersisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureBrown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in HumansMultimodality molecular imaging of the lung.Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models.Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors.Quantitative assessment of dynamic PET imaging data in cancer imaging.FDG PET-CT in follicular lymphoma: a case-based evidence review.Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens.Factors affecting the repeatability of gamma camera calibration for quantitative imaging applications using a sealed source.Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid TumorsQuantitative radiomics: impact of stochastic effects on textural feature analysis implies the need for standards.18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstructionNovel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules.Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.Comparison of the scanning linear estimator (SLE) and ROI methods for quantitative SPECT imaging.A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET ImagesA Digital Reference Object to Analyze Calculation Accuracy of PET Standardized Uptake Value.An artificial neural networks approach for assessment treatment response in oncological patients using PET/CT images.Computerized PET/CT image analysis in the evaluation of tumour response to therapy.Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials.Receiver operating characteristic (ROC) curve for classification of (18)F-NaF uptake on PET/CT.In vivo visualization of aromatase in animals and humans.A comparison of quantitative methods for clinical imaging with hyperpolarized (13)C-pyruvateIs There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response?Evaluation of Cross-Calibrated 68Ge/68Ga Phantoms for Assessing PET/CT Measurement Bias in Oncology Imaging for Single- and Multicenter TrialsPotential of PET-MRI for imaging of non-oncologic musculoskeletal disease.Morphology supporting function: attenuation correction for SPECT/CT, PET/CT, and PET/MR imaging.PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum.Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems.Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements.A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.Comparison of dose distribution for head and neck cancer patients with and without dose painting escalation during radiotherapy realized with tomotherapy unit.
P2860
Q26778452-D77E785D-EB50-4676-A368-E4B30E6EEA51Q27694674-953DE06D-9803-4BB5-9D42-FDC7E37CFC8DQ28074096-F9A9F66D-1193-4102-99BB-C2476FA740B5Q28077401-44F68590-D4A2-48F1-A8DA-7A2D7BB403C4Q28391110-EC9FBEAE-C50C-4562-ABC4-380C80BFFF99Q30248546-30DCD096-9522-4D7A-9523-17A0064DFBDAQ30364295-A9EF1546-41B7-4111-957B-6D9C520ED237Q30388052-0336B4A2-5FDD-4BE7-9E48-36DB70ED2A22Q30645097-8E761A03-BC08-4BD5-9CE2-11F69DA4DF8BQ30828860-67CCD0D0-4036-43F3-BE94-5C0FD348556FQ34346931-8D09D796-FA19-4329-B78C-7D1C8EEFAEB6Q35080079-9C2AA50D-7192-403F-8A2E-B6EBF750D197Q35190529-3D0ECD80-D1CA-4670-940B-6F455B3F948CQ35624676-3C6A9E7B-4D3A-4A22-887E-6E116645334CQ35868868-E87F9340-0D28-4CCA-B527-C4C70615D3CFQ35915904-E249253E-68C1-48A9-A84A-09FAF388391AQ35935680-BF1CDCEE-518A-4125-AA62-A56499DA6867Q36001031-1B8345D3-311A-4B98-80C7-90E825E898FDQ36023565-EB65A58F-C1A0-490B-9B95-C49C7C75F8CEQ36032610-BDC6DFFD-477A-42EC-8A76-11BF90AB4260Q36162513-EF081653-E2CB-4A0A-BE17-84C71A086B0CQ36201974-7DA8FDBE-B9F9-40DF-836D-5AAD3E027AB2Q36279127-019C0FEE-8DDF-44B3-9D91-288C10E60473Q36295403-E598C38B-D015-4093-A68F-A566BC1711C7Q36303559-056C6212-BAF6-4D93-BC8A-5F83261D040DQ36628451-3846D26C-AF92-483E-8322-E21215BEF9D3Q36665028-2206E0D7-090F-4490-9477-265DA205E675Q36802166-5F6CFCA5-B774-4F37-A019-D73E2869FEF0Q37194767-0A60D869-7866-4B8C-B9A0-A572CC01B048Q37297234-E0C7EAB8-872E-4785-BEB0-CEC029594C16Q37316201-24DBB52F-3F8E-41E8-8FF2-33FE44F62EAAQ37558197-6D266BC7-BA69-4FAB-9501-DCB25DEFF865Q37570051-1546F7A8-6832-4DA9-A432-180CD9884135Q37603786-17A2EE85-4AA1-4156-A295-AB2C18B469DCQ37606388-C8E8D37D-6404-49D7-990F-9B954894651AQ37633048-1D3BD852-A7D5-4E02-9B23-FB787EF968C2Q37721524-DF80E2E2-175B-4B90-8D3B-73E52C8EB062Q37721526-A65ACD73-741D-44D8-AE99-65120E1AB343Q38224477-9D297127-2AE1-4B86-B3D0-CBA8B633AC58Q38400756-7D47E62D-05C2-4440-8D8D-6E576F73F4BF
P2860
Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Positron emission tomography-c ...... assessing response to therapy
@ast
Positron emission tomography-c ...... assessing response to therapy
@en
Positron emission tomography-c ...... assessing response to therapy
@nl
type
label
Positron emission tomography-c ...... assessing response to therapy
@ast
Positron emission tomography-c ...... assessing response to therapy
@en
Positron emission tomography-c ...... assessing response to therapy
@nl
prefLabel
Positron emission tomography-c ...... assessing response to therapy
@ast
Positron emission tomography-c ...... assessing response to therapy
@en
Positron emission tomography-c ...... assessing response to therapy
@nl
P2860
P1476
Positron emission tomography-c ...... assessing response to therapy
@en
P2093
James W Fletcher
P2860
P304
P356
10.1053/J.SULT.2010.10.001
P577
2010-12-01T00:00:00Z